According to an announcement submitted to the Hong Kong Stock Exchange, Shenzhen Maiktian Biomedical Technology sold 38.9 million shares in Hong Kong at a price of HK$15.42 per share. According to calculations, the company plans to raise HK$600 million. The listing is expected to be traded on September 7. Morgan Stanley and Huatai International are co-sponsors.

According to an announcement submitted to the Hong Kong Stock Exchange, Shenzhen Maiktian Biomedical Technology sold 38.9 million shares in Hong Kong at a price of HK$15.42 per share. According to calculations, the company plans to raise HK$600 million. The listing is expected to be traded on September 7. Morgan Stanley and Huatai International are co-sponsors.